clinical trial · NCT05865028
A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
Elizabeth J Franzmann·phase2·recruiting·n = 32
Oropharyngeal DysplasiaOral Cavity DysplasiaOral Carcinoma in SituAPG-157
brief summary
The purpose of this study is to assess whether APG-157 can reduce the tumor size in participants with the study disease. Another purpose is to find out about the effects of APG-157 on certain tumor markers and oral rinses in participants with the study disease.
started
May 24, 2023
primary completion
May 24, 2027
completion
May 24, 2028
last updated
Jan 14, 2026
official title
Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol